Showing 1,721 - 1,740 results of 30,643 for search '(( 50 ((a decrease) OR (mean decrease)) ) OR ( e ((nn decrease) OR (fold decrease)) ))', query time: 0.89s Refine Results
  1. 1721
  2. 1722
  3. 1723
  4. 1724
  5. 1725
  6. 1726

    Decrease of the viral infectivity titer by marchantins. by Yuma Iwai (220294)

    Published 2011
    “…The cells were then treated with various concentrations of phytochemicals (3.1–50 µM), some of which decreased viral infectivity titer. …”
  7. 1727
  8. 1728
  9. 1729
  10. 1730
  11. 1731
  12. 1732
  13. 1733

    Simulated effects of increased pCREB combined with decreased pCaMKIIα on bistability. by Yili Zhang (540283)

    Published 2022
    “…However, decreasing <i>k</i><sub><i>basalp_CaMKII</i></sub> by ~50% blocked the bistable switch (red). …”
  14. 1734

    m 6A RNA Methylation Decreases Atherosclerotic Vulnerable Plaque Through Inducing T Cells by Chunmei Qi (739294)

    Published 2023
    “…Conclusion: After successfully establishing a vascular parkinsonism rabbit model, m 6A RNA methylation can decrease Th cells and vulnerable atherosclerotic plaques.…”
  15. 1735
  16. 1736
  17. 1737
  18. 1738

    VRK1 overexpression is seen in human breast cancer and is associated with decreased relapse-free survival. by Aye M. Mon (5714912)

    Published 2018
    “…Data for cancer subtypes are shown in boxes numbered 1–11: 1: benign breast neoplasm (rank 6459, 1.4 fold-change, NS), 2: breast carcinoma (rank 833, 1.5 fold-change, p = 3.83x10<sup>-5</sup>), 3: breast phyllodes tumor (rank 512, 1.2 fold-change, p = 0.002), 4: ductal breast carcinoma in situ (rank 1969, 1.5 fold-change, p = 0.002), 5: invasive breast carcinoma (rank 1060, 1.6 fold-change, p = 1.28x10<sup>-5</sup>), 6: invasive ductal and invasive lobular breast carcinoma (rank 941, 1.5 fold-change, p = 6.76x10<sup>-22</sup>), 7: invasive ductal breast carcinoma (rank 613, 1.5-fold change, p = 2.71x10<sup>-71</sup>), 8: invasive lobular breast carcinoma (rank 947, 1.3 fold-change, p = 3.64x10<sup>-28</sup>), 9: medullary breast carcinoma (rank 400, 1.8 fold-change, p = 3.25x10<sup>-12</sup>), 10: mucinous breast carcinoma (rank 1932, 1.4 fold-change, p = 7.41x10<sup>-10</sup>) and 11: tubular breast carcinoma (rank 1253, 1.4 fold-change, p = 1.24x10<sup>-17</sup>). …”
  19. 1739
  20. 1740